• Deracoxib–Doxorubicin Synergy in Protecting Canine Mammary C

  2026-04-30

  This study demonstrates that Deracoxib, a selective COX-2 inhibitor, significantly reduces doxorubicin-induced cytotoxicity and apoptosis in cultured normal canine mammary epithelial cells. The findings suggest a mechanistic link between nitric oxide modulation and cell protection, with practical implications for improving the safety of combination chemotherapy in veterinary oncology.

• Tankyrase Inhibition Suppresses HCC via Hippo Pathway Modula

  2026-04-30

  Jia et al. (2017) demonstrated that selective tankyrase 1/2 inhibitors, including G007-LK, suppress hepatocellular carcinoma (HCC) cell proliferation by modulating the Hippo signaling cascade. This mechanistic insight highlights a promising therapeutic avenue targeting YAP/TEAD transcriptional activity through stabilization of AMOTL1/2, adding to the rationale for tankyrase inhibition in both HCC and colorectal cancer research.

• NUAK1 Inhibition Lowers Pathological Tau in Alzheimer’s Mode

  2026-04-29

  This study provides robust evidence that phosphorylation of tau at Ser356, mediated by NUAK1, is closely associated with Alzheimer’s disease pathology. It further demonstrates that selective inhibition of NUAK1 with WZ4003 reduces pathogenic tau phosphorylation in human brain slice cultures, highlighting a promising experimental approach for targeting tau-driven neurodegeneration.

• Tigecycline: Glycylcycline Antibiotic in MDR Infection Resea

  2026-04-29

  Tigecycline empowers researchers to tackle multidrug-resistant (MDR) pathogens with robust, reproducible workflows. This guide delivers applied protocols, optimization strategies, and troubleshooting insights, leveraging both real-world study data and APExBIO's proven reagent quality.

• Rational Design of NIR-II IR-1061 Liposomes for Deep Vascula

  2026-04-28

  This study details the rational engineering of IR-1061-loaded liposomal nanosystems to optimize near-infrared II (NIR-II) fluorescence for in vivo vascular imaging. By systematically varying liposome charge and dye concentration, the authors reveal how electrostatic interactions and aggregation state determine fluorescence efficiency and imaging performance, offering actionable guidelines for high-resolution, long-circulating angiography.

• Erastin: Ferroptosis Inducer Shaping Translational Oncology

  2026-04-28

  Erastin, a small molecule ferroptosis inducer, is redefining the strategic landscape for cancer biology by enabling selective, iron-dependent cell death in RAS/BRAF-mutant tumors. This thought-leadership article unpacks the mechanistic rationale, experimental protocols, and emerging clinical synergies, while guiding translational researchers in optimizing ferroptosis assays and capitalizing on novel combination strategies. Drawing on pivotal evidence—including recent advances in immune-oncology—this article elevates the discussion beyond standard product pages, highlighting the translational potential and workflow best practices for deploying Erastin in advanced cancer research.

• p53/PUMA-Mediated Apoptosis by WRN Inhibition in MSI CRC

  2026-04-27

  This study elucidates the mechanism behind the synthetic lethality observed when Werner (WRN) helicase is inhibited in mismatch repair (MMR)-deficient, microsatellite instability (MSI) colorectal cancers. By identifying p53 and its downstream effector PUMA as critical mediators of apoptosis following WRN depletion, the research highlights a promising therapeutic vulnerability in p53-wildtype MSI CRCs.

• Polybrene (Hexadimethrine Bromide): Precision in Viral Gene

  2026-04-27

  Polybrene (Hexadimethrine Bromide) 10 mg/mL accelerates lentiviral and retroviral gene delivery by neutralizing cell-virus repulsion, with proven boosts to DNA transfection even in refractory cell lines. Advanced workflows and troubleshooting insights enable researchers to maximize efficiency while minimizing cytotoxicity, redefining the reagent's value beyond classic protocols.

• Transcriptomic Insights: 6-Thioguanine Inhibits MCF-7 via DN

  2026-04-26

  This study elucidates the tumor-inhibitory mechanisms of 6-thioguanine in MCF-7 breast cancer cells, specifically highlighting the silencing of DNMT1 and downstream effects on apoptosis and cell cycle arrest. These findings provide a molecular rationale for repurposing thioguanine in breast cancer research and contribute to the growing evidence base for DNMT1-targeted therapies.

• AO/PI Double Staining Kit: Practical Workflow for Cell Viabi

  2026-04-25

  The AO/PI Double Staining Kit enables rapid, differential assessment of cell viability, apoptosis, and necrosis by combining Acridine Orange and Propidium Iodide fluorescent staining. It is best suited for cell biology research where discrimination of live, apoptotic, and necrotic cells is required, but is not intended for mechanistic or in vivo applications. Researchers should adhere strictly to the kit's storage and protocol recommendations to ensure data reliability.

• Meropenem (SKU A5124): Workflow Reliability in Resistance Re

  2026-04-24

  This article explores practical laboratory challenges in cell viability and resistance modeling, demonstrating how Meropenem (SKU A5124) from APExBIO supports reproducible, data-driven research on Gram-negative and Gram-positive pathogens. Through scenario-based Q&A, we detail assay compatibility, protocol optimization, and vendor selection considerations for biomedical scientists.

• Long-Term Degarelix Acetate for Chemical Castration in Goats

  2026-04-24

  This study rigorously evaluated the sustained administration of the GnRH receptor antagonist degarelix acetate as a chemical castration method in male goats. Repeated degarelix dosing led to durable suppression of testicular hormones and spermatogenesis, providing strong evidence for its effectiveness and highlighting key parameters for translational research.

• CK2 Inhibition in Cancer and Viral Research: Strategic Insig

  2026-04-23

  This thought-leadership article explores the mechanistic and translational implications of targeting CK2 with CX-4945 (Silmitasertib), highlighting recent evidence from cancer and virology. It offers strategic guidance for researchers seeking to bridge oncology and infectious disease research, contextualizes APExBIO's CX-4945 in the competitive landscape, and outlines protocols and future outlooks.

• (+)-Bicuculline: Technical Guide for GABAA Receptor Antagoni

  2026-04-23

  (+)-Bicuculline is a classical GABAA receptor antagonist intended for dissecting GABAergic signaling and studying synaptic NMDA receptor modulation in neuroscience research. It is not suitable for diagnostic or clinical applications. Proper solubility handling and storage are essential for experimental reliability.

• Tetraethylammonium Chloride: Precision Tools for K+ Channel

  2026-04-22

  Tetraethylammonium chloride (TEAC) from APExBIO delivers unparalleled specificity for potassium channel inhibition, supporting workflows spanning vascular, neurological, and metabolic research. This article dissects optimized protocols, advanced applications, and troubleshooting strategies to unlock the full translational impact of TEAC in ion channel and vasorelaxant studies.

15564 records 1/1038 page Next 12345 下5页 Last page